Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic LeukemiaRebecca Gardner, Michael C. Jensen, Olivia Finney et al.|Blood|2018Cited by 65